FAKTOR-OPTIONSSCHEIN - GENMAB Stock

Certificat

DE000MG1KCD4

Market Closed - Börse Stuttgart 14:17:12 2024-06-14 EDT
12.57 EUR +0.48% Intraday chart for FAKTOR-OPTIONSSCHEIN - GENMAB
Current month+12.03%
1 month+19.26%
Date Price Change
24-06-14 12.57 +0.48%
24-06-13 12.51 +0.72%
24-06-12 12.42 +5.25%
24-06-11 11.8 +3.60%
24-06-10 11.39 +1.06%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 02:17 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying GENMAB A/S
Issuer Morgan Stanley
WKN MG1KCD
ISINDE000MG1KCD4
Date issued 2024-04-03
Strike 2,736 kr
Maturity Unlimited
Parity 9.66 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 12.69
Lowest since issue 9.99
Spread 0.2
Spread %1.56%

Company Profile

Genmab A/S specializes in the research and development of human and therapeutic antibodies intended for treating cancers, infectious diseases, rheumatoid arthritis, etc. Net sales break down by type of income as follows: - royalties (83.2%); - income from research and development (12.4%); - other (4.4%): primarily income from partnership agreement. At the end of 2023, the group had a portfolio of more than 20 products in clinical development phase and 20 in preclinical development phase. Denmark accounts for all net sales.
Sector
-
More about the company

Ratings for Genmab A/S

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Genmab A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
1,832 DKK
Average target price
2,464 DKK
Spread / Average Target
+34.46%
Consensus